摘要
以口服肝泰乐作对照组，观察活血化瘀方治疗失代偿期肝硬化的临床疗效。治疗３个月后，治疗组血清ＡＬＴ、胆红素、白蛋白较对照组明显好转（Ｐ＜０．０５或０．０１），腹水消退快（Ｐ＜０．０１），症状改善优于对照组。活血化瘀方还能提高患者血液ＣＤ３、ＣＤ４，降低ＣＤ８，促进ＨＢｓＡｇ转阴。提示活血化瘀是治疗肝硬化的有效方法，并能增强患者的细胞免疫功能。
To investigate the therapeutic effects and T-lymphocyte subset changes of removing blood stasis recipe(RBSR)on decompensated cirrhosis, 20 patients in treatment group were treated with RBSR and 16 patients in control group were treated with Gantaile for 3 months,respectively. At the end of treatment, in treatment group, sera ALT, bilirubin fell and albumin rose significantly compared with those in control group (P<0. 01 or 0. 05), and the time of ascites disappearance was shorter and symptoms improved more rapidly. The RBSR could raise blcod CD_3,CD_4,decrease CD_8,and convert sera HBsAg to negation as well. It is suggested that the RBSR can cure cirrhosis effectively and improve the cyto-immune function.
出处
《滨州医学院学报》
1996年第5期441-442,共2页
Journal of Binzhou Medical University
关键词
活血化瘀
T淋巴细胞亚群
治疗
肝硬变
cirrhosis
removing blood stasis recipe
therapy
cyto-immune
